Home Cart Sign in  
Chemical Structure| 39562-70-4 Chemical Structure| 39562-70-4

Structure of Nitrendipine
CAS No.: 39562-70-4

Chemical Structure| 39562-70-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Nitrendipine is a dihydropyridine calcium channel blocker with an IC50 of 95 nM.

Synonyms: BAY-E-5009; Bayotensin; Nitrendipine, Bayotensin, Baypress, Nidrel, Deiten

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Nitrendipine

CAS No. :39562-70-4
Formula : C18H20N2O6
M.W : 360.36
SMILES Code : O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC([N+]([O-])=O)=C2)OCC
Synonyms :
BAY-E-5009; Bayotensin; Nitrendipine, Bayotensin, Baypress, Nidrel, Deiten
MDL No. :MFCD00082255
InChI Key :PVHUJELLJLJGLN-UHFFFAOYSA-N
Pubchem ID :4507

Safety of Nitrendipine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H312-H332
Precautionary Statements:P280

Isoform Comparison

Biological Activity

Target
  • Calcium Channel

    Calcium channel, IC50:95 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Bovine aortic endothelial cells (BAEC) 0.1 to 100 µM 3 minutes Nitrendipine significantly increased intracellular calcium concentration in BAEC in a concentration-dependent manner, from a control level of 118±10 nM by 11±2 nM (0.1 μM), 23±3 nM (1 μM), 34±4 nM (10 μM), and 47±5 nM (100 μM). This elevation is mainly due to a gadolinium-sensitive calcium influx from the extracellular space rather than a calcium release from intracellular stores. Br J Pharmacol. 1996 Aug;118(8):1899-904

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Wistar rats Hypertensive model Oral 200 mg/kg Single dose To compare the bioavailability of nanocrystals, physical mixture, and commercial tablet. Results showed that the Cmax of the nanocrystals was approximately 15-fold and 10-fold greater than that of physical mixture and commercial tablet, respectively, and the AUC0→24 was approximately 41-fold and 10-fold greater, respectively. AAPS PharmSciTech. 2011 Dec;12(4):1136-43

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00892892 Chronic Kidney Disease ... More >> Hypertension Less << Phase 4 Withdrawn - Germany ... More >> University of Erlangen-Nuremberg, CRC, med. Clinic 4 Erlangen, Bavaria, Germany, 91054 Less <<
NCT01074281 - Completed - -
NCT02088450 Isolated Systolic Hypertension Phase 2 Terminated - -
NCT03527719 Hypertension Not Applicable Recruiting December 31, 2022 China, Liaoning ... More >> The First Affiliated Hospital of China Medical University Recruiting Shenyang, Liaoning, China, 110001 Less <<
NCT02217852 Hypertension Phase 4 Unknown July 2016 China, Sichuan ... More >> West China Hospital Not yet recruiting Chengdu, Sichuan, China, 610041 Less <<
NCT00751829 Isolated Systolic Hypertension Phase 3 Completed - Germany ... More >> Munich, Germany Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.78mL

0.56mL

0.28mL

13.88mL

2.78mL

1.39mL

27.75mL

5.55mL

2.78mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories